Similarly, minocycline, an inhibitor of MMP-9, has been related to better cognitive outcomes after a subarachnoid hemorrhage [127] or in hypertensive small vessel disease [128]. The gene discussed is MMP9; the disease is subarachnoid hemorrhage.